secwatch.observer — SEC 8-K summary
======================================

Issuer:     Chemours Co (CC)
CIK:        0001627223
Form:       8-K/A
Filed at:   2022-12-27T23:59:59+00:00
Accession:  0000950170-22-027049
Event type: leadership
Sentiment:  negative
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemours board member Bell resigns over disagreement on abortion, transgender benefits
--------------------------------------------------------------------------------

- Bradley J. Bell resigned effective Jan 2, 2023, citing moral opposition to employee benefits coverage for transgender procedures, abortions, and travel for abortion services.
- Bell served on the Compensation Committee and Nominating and Corporate Governance Committee.
- In his resignation letter, Bell called the benefits 'morally and ethically wrong' and stated he could not reconcile his board role with his beliefs.
- Bell is involved with women's medical clinics opposing abortion; he questioned whether the benefits reflect employee demand or a cultural statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1627223/000095017022027049/0000950170-22-027049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1627223/000095017022027049/cc-20221221.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-027049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer